ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

BDTX Black Diamond Therapeutics Inc

6.82
0.23 (3.49%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Black Diamond Therapeutics Inc BDTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.23 3.49% 6.82 23:00:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.67 6.60 7.14 6.96 6.59
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:05GLOBEBlack Diamond Therapeutics Announces Presentations at the..
11/4/202407:00GLOBEBlack Diamond Therapeutics Announces Changes to Board of..
07/4/202417:00GLOBEBlack Diamond Therapeutics Presents Novel Real-World..
03/4/202407:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
12/3/202407:00GLOBEBlack Diamond Therapeutics Reports Fourth Quarter and Full..
11/3/202412:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/3/202415:30GLOBEBlack Diamond Therapeutics Announces Upcoming Presentation..
28/2/202407:00GLOBEBlack Diamond Therapeutics to Participate in the TD Cowen..
15/2/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:04EDGAR2Form 8-K - Current report
04/1/202407:07EDGAR2Form 8-K - Current report
04/1/202407:00GLOBEBlack Diamond Therapeutics Announces Corporate Update and..
13/12/202306:08EDGAR2Form 8-K - Current report
13/12/202306:00GLOBEBlack Diamond Therapeutics Announces Topline Results from..
07/11/202307:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
06/11/202306:45GLOBEBlack Diamond Therapeutics Reports Third Quarter 2023..
06/11/202306:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202306:10EDGAR2Form 8-K - Current report
14/10/202311:30GLOBEBlack Diamond Therapeutics Presents Dose Escalation Data..
04/10/202311:14GLOBEBlack Diamond Therapeutics to Present Preclinical and..
18/9/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202306:12EDGAR2Form 8-K - Current report
18/9/202306:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
11/9/202307:00GLOBEBlack Diamond Therapeutics Announces First Patients Dosed in..
05/9/202307:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
11/8/202306:30GLOBEBlack Diamond Therapeutics Reports Second Quarter 2023..
11/8/202306:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:22EDGAR2Form 8-K - Current report
30/6/202315:03EDGAR2Form 8-K - Current report
30/6/202315:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/6/202319:57GLOBEBlack Diamond Therapeutics Announces Pricing of Public..
29/6/202305:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202315:23GLOBEBlack Diamond Therapeutics Announces Proposed Public..
27/6/202306:00GLOBEBlack Diamond Therapeutics Announces Initial Dose Escalation..
13/6/202307:00GLOBEBlack Diamond Therapeutics Announces Promotion of Melanie..
02/6/202307:00GLOBEBlack Diamond Therapeutics to Present at the Jefferies..
09/5/202306:30GLOBEBlack Diamond Therapeutics Reports First Quarter 2023..

Su Consulta Reciente

Delayed Upgrade Clock